KN
Kiniksa Pharma
KNSA·NASDAQHamilton BMFounded 2015150 employees
Mid CapbiotechPublicImmunologyRare DiseaseCardiology
Platform: IL-1 Riley-Day
Market Cap
$2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (KNSA)
Loading KNSA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KNS-8287 | KNS-8287 | Phase 2 | 1 | Nectin-4 | Wet AMDFL | ||
| KNS-1946 | KNS-1946 | Phase 3 | 3 | DLL3 | MyelofibrosisRett |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)